Semaglutide has certainly taken Australia by storm.
Now with more than one option available it is likely many consultations will include questions.
In this webcast on 15 October, Dr Gary Deed will cover the differences between the options, advantages and disadvantages, and importantly which option is best for a particular patient, and present the latest evidence and recommendations to help navigate this very topical area of practice.
How do the CPD options work?
- Attend the webcast and earn 2 hrs CPD in the Educational Activities category by attending the webcast lecture and completing the evaluation (RACGP & ACRRM approved)
- Complete the optional post-webcast quiz and earn 0.5 hrs CPD in the Reviewing Performance category (RACGP & ACRRM approved)
- Complete the optional Patient Case Review and earn a further 0.5 hrs CPD in the Reviewing Performance category (RACGP & ACRRM approved)
- Undertake the optional Micro Audit and gain 1 hrs CPD in the Measuring Outcomes category (RACGP & ACRRM approved)
Other professions can self-claim up to 4 hrs CPD.
Attendees will receive Certificate of Attendance approx. four weeks post-webcast
Don’t miss out, REGISTER NOW.
Topics include:
Work Up of a Breast Lump in GP – Practical Tips and Traps
Dr Sally Meade, General surgeon; Greenslopes Private Hospital
For most women and indeed most GPs, a newly discovered breast lump is cancer until proven otherwise. In this very practical and valuable talk, Dr Sally Meade will provide a refresher on assessing and managing breast lumps, including an update on the most appropriate investigations, imaging and likely diagnosis. She will also be giving an overview of the latest thinking and recommendations for other breast presentations including breast pain and nipple discharge..
Semaglutide – Which Dose for Which Patient?
Dr Gary Deed, General Practitioner; Coorparoo, QLD; National Chair, RACGP Diabetes Specific Interest Group
Semaglutide has certainly taken Australia by storm. Now with more than one option available it is likely many consultations will include questions and discussions about the differences between the options, advantages and disadvantages, and importantly which option is best for a particular patient. In this talk Dr Gary Deed will address all these issues and present the latest evidence and recommendations to help navigate this very topical area of practice.
Triple Therapy in Asthma – Case Studies in Primary Care
Dr Andrew Scroop, Respiratory Physician; Founding Director of Respiratory Consultants, St Andrews Medical Centre
While most adults with asthma can be readily and effectively managed in general practice, there exists a small group of patients who continue to have symptoms despite our best efforts.
In this presentation, Dr Andrew Scroop will present a number of case studies that effectively demonstrate the best evidence-based approach to such patients. Starting with confirming the diagnosis of asthma and identifying any confounders all the way to determining which patients might benefit from triple therapy and when and how it should be initiated.
RSV Update
Prof Paul Griffin, Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland
The new vaccines for Respiratory Syncytial Virus are here. And patients are asking about them, courtesy of a far-reaching public awareness campaign about RSV. In this talk, Professor Paul Griffin will provide a timely update on all that treating health professionals need to know about these vaccines including the current ATAGI recommendations on who should be vaccinated and when, their effectiveness, side-effects, cost and the practical differences between Arexvy and Abrysvo, the two RSV vaccines currently available.
Date:
Tuesday 15th October 2024
Time:
7pm – 9pm AEDT (NSW, VIC, TAS, ACT)
6pm – 8pm AEST (QLD)
6:30pm – 8:30pm ACDT (SA)
5:30pm – 7:30pm ACST (NT)
4pm – 6pm AWST (WA)
